<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have studied the levels of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase in drug-resistant and -sensitive human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines to examine a possible involvement of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase (GST) in multidrug resistance mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>No increase in the activity of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase was detected in myelogenous <z:hpo ids='HP_0001909'>leukemia</z:hpo> K562 resistant to adriamycin (K562/ADM), <z:mp ids='MP_0003579'>ovarian carcinoma</z:mp> cell line A2780 resistant to adriamycin (2780AD), or <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> cell line CCRF-CEM resistant to vinblastine (CEM-VLB100), compared with the drug-sensitive parent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>The human <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cell lines Hattori and MCF-7 had a 12- to 63-fold lower level of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase activity than K562, A2780, CCRF-CEM, and their drug-resistant sublines </plain></SENT>
<SENT sid="3" pm="."><plain>Induction of ADM resistance in Hattori did not increase the activity of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase </plain></SENT>
<SENT sid="4" pm="."><plain>However, induction of <z:chebi fb="0" ids="23359">colchicine</z:chebi> resistance in MCF-7 resulted in a 70-fold increase in the activity of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase </plain></SENT>
<SENT sid="5" pm="."><plain>A <z:mp ids='MP_0003171'>revertant</z:mp> of the <z:chebi fb="0" ids="23359">colchicine</z:chebi>-resistant MCF-7 contained a level of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase activity similar to that of the resistant subline </plain></SENT>
<SENT sid="6" pm="."><plain>The increase of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase activity did not alter the sensitivity of the cell to cytotoxic drugs </plain></SENT>
<SENT sid="7" pm="."><plain>The increased activity was due to the appearance of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e>, as shown by <z:e sem="disease" ids="C0877008" disease_type="Disease or Syndrome" abbrv="">enzyme inhibition</z:e> using anti-<z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> antibody </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings indicate that increased cellular <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase activity is not associated with the development of multidrug resistance </plain></SENT>
</text></document>